NCT03523065Recruiting
Chinese PD-GBA Registry
The Chinese Parkinson's Disease With GBA Variants Registry
Source: ClinicalTrials.gov · Last updated 29 May 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the Chinese Parkinson's disease with GBA variants Registry (CPD-GBAR) is to develop a database of patients of Parkinson's disease with Glucocerebrosidase (GBA) gene variants in mainland China.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 1 May 2018
- Start date
- 1 Feb 2017
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Parkinson disease
- NCT number
- NCT03523065
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Feb 2017 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with GBA gene variants.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hospital of Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.